Type of Financing |
Jan |
Feb |
Mar |
Apr |
May |
June |
July |
Aug |
Sep |
Oct |
Nov |
Total ($M) |
Public offerings |
475.6 |
974.2 |
1,053.2 |
257.4 |
758.5 |
487.1 |
546.1 |
2,288.6 |
123.3 |
909.1 |
72.0 |
7,950.9 |
Public/other |
245.3 |
207.6 |
1,424.2 |
350.6 |
206.4 |
106.8 |
329.5 |
1,337.3 |
302.8 |
359.9 |
446.0 |
5,318.5 |
Private biotechs |
250.5 |
222.7 |
301.4 |
200.1 |
201.6 |
192.5 |
326.9 |
273.0 |
320.5 |
331.3 |
610.9 |
3,229.1 |
Total ($M) |
971.4 |
1,404.4 |
2,778.7 |
808.1 |
1,166.5 |
786.4 |
1,202.5 |
3,898.9 |
746.6 |
1600.3 |
1,128.9 |
16,498.5 |
Notes: Public offerings = Initial, follow-on. Private biotechs = Financings of private firms. Public/other = Other financings of public companies, including loans, bridge financings, exercises of warrants, debt offerings, rights offerings, standard private placements, PIPE financings and institutional offerings of registered stock. |